LivaNova (LIVN) Cash & Equivalents (2014 - 2026)

LivaNova has disclosed Cash & Equivalents across 13 years of filings, most recently posting $516.6 million for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 12.97% year-over-year to $516.6 million; the TTM figure through Jun 2026 stood at $516.6 million (down 12.97% YoY), while the FY2025 annual figure was $635.6 million, up 48.2% from the prior year.
• Cash & Equivalents came in at $516.6 million for Q2 2026 at LivaNova, down from $539.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $738.4 million in Q1 2025 to a low of $275.2 million in Q3 2022.
• Average Cash & Equivalents over 5 years is $416.8 million, with a median of $321.4 million recorded in 2022.
• Year-over-year, Cash & Equivalents soared 138.83% in 2025 and dropped 26.91% in 2026.
• Over 5 years, Cash & Equivalents stood at $301.4 million in 2022, then gained by 3.29% to $311.4 million in 2023, then surged by 37.73% to $428.9 million in 2024, then soared by 48.2% to $635.6 million in 2025, then retreated by 18.71% to $516.6 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $516.6 million in Q2 2026, $539.7 million in Q1 2026, and $635.6 million in Q4 2025.